FutureFemHealth

FutureFemHealth

Home
Work with us / Advertise
CensHERship
Archive
About
Vanderbilt University spinout Septagen launches to target overlooked driver of women’s heart disease
Addressing a leading cause of death in women
35 mins ago • Anna O'Sullivan
Q1 funding: what $1.24b into women’s health really tells us
Platform expansion, deep tech, and why the category is starting to blur
Apr 17 • Anna O'Sullivan
FertilAI secures CE mark for predictive AI tools targeting fertility treatment timing
The newly cleared platform focuses on one of the most complex and variable aspects of fertility treatment
Apr 16 • Anna O'Sullivan
Osteoboost raises $8m to scale FDA-cleared wearable targeting bone loss in postmenopausal women
Interest grows in non-drug interventions for age-related conditions
Apr 15 • Anna O'Sullivan
England's Women's Health Strategy to include £1.5m femtech fund as refresh focuses on patient voice and waiting lists
UK Government announced the refreshed strategy
Apr 15 • Anna O'Sullivan
💌 Issue 142: Muse deploys its portfolio into sport | ovarian cancer triage | peptides emerge | Eka closes €91m fund
The global weekly briefing on women's health innovation and Femtech
Apr 15 • Anna O'Sullivan
Sibel Health secures FDA clearance for wireless maternal-fetal monitoring platform
Alternative to traditional wired monitoring used in hospitals
Apr 12 • Anna O'Sullivan
Muse Capital deploys portfolio of women’s health startups into elite sport with Optima launch
Sport has ignored the unique needs of female athletes
Apr 12 • Anna O'Sullivan
💌 Issue 141: PCOS to rename | Sub-Q Bionic raises $1.5m for lymphedema | egg freezing cost guarantees | 'sandwich generation support'
The global weekly briefing on women's health innovation and Femtech
Apr 8 • Anna O'Sullivan
The PCOS opportunity: a deep dive into this unsolved area of women’s health
No cure, a thin pharmaceutical pipeline and huge unmet need. Here are the innovators solving for this space.
Apr 8 • Anna O'Sullivan
Women’s Health Week USA 2026: what to expect at the sector’s most commercially-focused gathering
We're entering the era of scale.
Apr 8 • Anna O'Sullivan
💌 Issue 140: WHOOP raises $575m as Garmin moves into care | IVF crosses into genetic selection | The real bottleneck in women’s health
The global weekly briefing on women's health innovation and Femtech
Apr 1 • Anna O'Sullivan
© 2026 FutureFemHealth Ltd · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture